Dengue - Quo tu et quo vadis?

被引:186
|
作者
Chen, Rubing [1 ]
Vasilakis, Nikos [1 ,2 ,3 ,4 ]
机构
[1] Univ Texas Galveston, Dept Pathol, Med Branch, Galveston, TX 77555 USA
[2] Univ Texas Galveston, Ctr Biodef & Emerging Infect Dis, Med Branch, Galveston, TX 77555 USA
[3] Univ Texas Galveston, Inst Human Infect & Immun, Med Branch, Galveston, TX 77555 USA
[4] Univ Texas Galveston, Ctr Trop Dis, Med Branch, Galveston, TX 77555 USA
来源
VIRUSES-BASEL | 2011年 / 3卷 / 09期
关键词
dengue virus (DENV); arbovirus; mosquito; evolution; phylogenetics; TRANS-OVARIAL TRANSMISSION; TYPE-3; GENOTYPE-III; ANTIBODY-DEPENDENT ENHANCEMENT; AEDES-AEGYPTI DIPTERA; ADJUSTED LIFE YEARS; VIRUS SEROTYPE 4; HEMORRHAGIC-FEVER; MOLECULAR EPIDEMIOLOGY; VERTICAL TRANSMISSION; ECONOMIC-IMPACT;
D O I
10.3390/v3091562
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Dengue viruses (DENV) are by far the most important arboviral pathogens in the tropics around the world, putting at risk of infection nearly a third of the global human population. DENV are members of the genus Flavivirus in the Family Flaviviridae and comprise four antigenically distinct serotypes (DENV-1-4). Although they share almost identical epidemiological features, they are genetically distinct. Phylogenetic analyses have revealed valuable insights into the origins, epidemiology and the forces that shape DENV evolution in nature. In this review, we examine the current status of DENV evolution, including but not limited to rates of evolution, selection pressures, population sizes and evolutionary constraints, and we discuss how these factors influence transmission, pathogenesis and emergence.
引用
收藏
页码:1562 / 1608
页数:47
相关论文
共 50 条
  • [1] Dengue in International Travelers: Quo Vadis?
    Wilder-Smith, Annelies
    [J]. JOURNAL OF TRAVEL MEDICINE, 2013, 20 (06) : 341 - 343
  • [3] MULTINATIONAL PHARMACEUTICAL RESEARCH - QUO VADIS ET QUO MODO
    JACK, DB
    [J]. PHARMACY INTERNATIONAL, 1982, 3 (10): : 313 - 314
  • [4] NOTES – Quo vadis?NOTES – Quo vadis?
    J. Jähne
    [J]. Der Chirurg, 2010, 81 (5): : 405 - 406
  • [5] PSA - Quo vadis? [PSA - Quo vadis?]
    Börgermann C.
    Loertzer H.
    Luboldt H.-J.
    Hammerer P.
    Fornara P.
    Graefen M.
    Rübben H.
    [J]. Der Urologe, 2009, 48 (9): : 1008 - 1017
  • [6] Quo vadis university? (Quo vadis universidad?)
    Sancho-Gil, Juana M.
    [J]. CULTURE EDUCATION, 2021, 33 (02): : 397 - 411
  • [7] Quo vadis, Kohorte?Quo vadis cohorts?
    I. Pigeot
    W. Ahrens
    [J]. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2012, 55 : 753 - 755
  • [8] Quo vadis, Proktologe?Quo vadis, proctologist?
    Michael H. Roblick
    [J]. coloproctology, 2023, 45 (4) : 219 - 220
  • [9] Quo vadis NOTES?Quo vadis NOTES?
    G. O. Spaun
    L. L. Swanström
    [J]. European Surgery, 2008, 40 (5) : 211 - 219
  • [10] Quo vadis Alzheimer?Quo vadis Alzheimer?
    Frank Jessen
    Christian Haass
    [J]. Der Nervenarzt, 2019, 90 (9) : 881 - 883